# Lasix for the Prevention of De Novo Postpartum Hypertension

> **NCT04752475** · PHASE3 · COMPLETED · sponsor: **Columbia University** · enrollment: 82 (actual)

## Conditions studied

- Postpartum Pregnancy-Induced Hypertension
- Postpartum Preeclampsia
- Hypertension, Pregnancy-Induced
- Hypertension

## Interventions

- **DRUG:** Furosemide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04752475
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-20
- **Primary completion:** 2022-04-18
- **Final completion:** 2022-05-28
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2024-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04752475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04752475, "Lasix for the Prevention of De Novo Postpartum Hypertension". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04752475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*